Skip to content
https://media.matheson.com/wp-content/uploads/2025/08/Life_Science.mp4

Life Sciences and Healthcare

Life Sciences

‘Very responsive, knowledgeable, approachable. Always willing to go above and beyond in their service and advice. Always clear in the scope of their instructions.’

Legal 500 2024 – Healthcare and Life Sciences

Our multidisciplinary Life Sciences and Healthcare Group provides solution focused and sector specific commercial advice to leading life sciences and healthcare companies and investors.

Ireland is ideally located to provide access to international markets and many companies see Ireland, not just as a gateway to Europe, but as a base for their international headquarter operations.  At Matheson we are at the heart of this vibrant and innovative sector. 

Our experience and sector specific knowledge sets us apart within the Irish market, with our team having advised on the leading and most complex M&A transactions, restructuring mandates and regulatory issues within the Irish Life Sciences and Healthcare sector. 

Our Service Offering

Corporate Establishment and Expansion Projects

Read More

Spin-Offs and Corporate Reorganisation Projects

Read More

Life Sciences M&A Transactions

Read More

Healthcare M&A Transactions

Read More

Regulatory Matters

Read More

Life Sciences Litigation

Read More

IP, Technology and Innovation

Read More

Environmental, Social and Governance

Read More

International Tax and Life Sciences

Read More

Recent Life Sciences Deal Announcements

Experience Highlight
05/08/2025

Matheson advised private investment firm Graham Partners on its acquisition of medical device manufacturer Smithstown Light Engineering

Experience Highlight
24/06/2025

Matheson advised Shrieve Chemical Company on its acquisition of Carbon Chemicals Group Limited

Experience Highlight
06/01/2025

Matheson advised ISIF on a further investment in FIRE1

Experience Highlight
29/10/2024

Matheson advised ProductLife Limited on the acquisition of Elara Pharmaservices

Experience Highlight
24/10/2024

Matheson advised Trinity Biotech plc on its acquisition of Epicapture Limited

Experience Highlight
23/09/2024

Matheson advised Trinity Biotech plc on its acquisition of Metabolomic Diagnostics Limited

Experience Highlight
24/07/2024

Matheson advised Andera Partners on its investment into Kestra

Experience Highlight
01/05/2024

Matheson advised Novo Nordisk on its acquisition of its first manufacturing facility in Ireland

News and Insights

View All Insights
Insights
30/10/2025

App Stores may be Subject to EU Medical Device Regulatory Frameworks

Read More
Insights
09/09/2025

Update on the Upcoming Expiry of the IPHA Medicine Pricing Agreement

Read More
Insights
28/05/2025

Irish FDI Screening Regime – Application to The Life Sciences Sector

Read More
Insights
15/04/2025

New High Court Practice Directions for Clinical Negligence Claims

Read More
Insights
14/04/2025

IPHA Publish New Code of Practice for the Pharmaceutical Industry

Read More
News
26/03/2025

Matheson Sponsors the Guaranteed Irish Business Awards 2025

Read More
Insights
16/12/2024

Lexology Panoramic: Healthcare Enforcement and Litigation 2025 (Ireland)

Read More
Insights
01/07/2024

Corporate Sustainability Due Diligence Directive

Read More

Life Sciences Team

Emma

Doherty

Partner

Pat

English

Partner

Seóna

O'Donnellan

Partner

Gráinne

Boyle

Partner

Kieran

Trant

Partner

David

Fitzgibbon

Partner

John

Coary

Partner

David

Jones

Partner

Susanne

McMenamin

Partner

Brian

Doohan

Partner

Matthew

Broadstock

Partner

Catherine

O'Meara

Partner

Kate

McKenna

Partner

Nicola

Dunleavy

Consultant

Rebecca

Ryan

Partner

Justine

Sayers

Partner

Garret

Farrelly

Partner

Sarah Jayne

Hanna

Partner

Simon

Shinkwin

Partner

Marie

McGinley

Partner

© 2025 Matheson LLP | All Rights Reserved